Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

19.01.2026

1 Biochem Biophys Res Commun
1 BMC Cancer
6 BMC Gastroenterol
1 Dig Dis Sci
1 Endoscopy
1 Gut
9 Hepatology
2 J Gastroenterol Hepatol
2 J Hepatol
1 PLoS Med
3 Radiology



    Biochem Biophys Res Commun

  1. FANG X, Liang Z, Zhang Z, Tao M, et al
    Natural exosome-like nanovesicles from Smilax China rhizome induce mitophagy-dependent ferroptosis in hepatocellular carcinoma via GPX4/ACSL4 axis.
    Biochem Biophys Res Commun. 2026;800:153270.
    >> Share


    BMC Cancer

  2. GUASTELLA R, Perri G, Bassi D, Canitano N, et al
    Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trial.
    BMC Cancer. 2026;26:44.
    >> Share


    BMC Gastroenterol

  3. ZOU J, Tian F, Cui S, Hou J, et al
    Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis.
    BMC Gastroenterol. 2025;26:25.
    >> Share

  4. LI Y, Jiang C, Wang Z, Liu L, et al
    Application of laparoscopic liver surgery techniques in laparoscopic thermal ablation of liver tumors.
    BMC Gastroenterol. 2025;26:19.
    >> Share

  5. ZHONG Z, Xu M, Luo X, Tan J, et al
    Global, regional, and national burden of NAFLD in adults aged 20-49 years (1990-2021): a comprehensive analysis of trends, decomposition, and health inequality.
    BMC Gastroenterol. 2025;26:23.
    >> Share

  6. KHACHIDZE T, Sulaberidze G, Barbakadze G
    Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease in the adult Georgian population: a nationwide multiregional clinic-based study.
    BMC Gastroenterol. 2025;26:17.
    >> Share

  7. OZONO Y, Kawakami H, Hatada H, Uchiyama N, et al
    Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice.
    BMC Gastroenterol. 2026 Jan 15. doi: 10.1186/s12876-026-04610.
    >> Share

  8. CAI F, Yu J, Qin L
    Impact of preoperative triglyceride levels on hepatic encephalopathy development in TIPS patients: a retrospective cohort study.
    BMC Gastroenterol. 2026 Jan 12. doi: 10.1186/s12876-025-04583.
    >> Share


    Dig Dis Sci

  9. WILLIAMS EE, Lammert C, Vuppalanchi R
    Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.
    Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-026-09672.
    >> Share


    Endoscopy

  10. SOGA K, Yamaguchi M, Kuwada M, Shirahashi R, et al
    A rare case of hepatic hilar lymphangioma diagnosed using endoscopic and transabdominal ultrasonography.
    Endoscopy. 2026;58.
    >> Share


    Gut

  11. DUTTA RK, Du K, Ren N, Umbaugh DS, et al
    Zinc-dependent RNA-binding protein controls hepatocyte senescence and recovery from alcohol-related liver failure.
    Gut. 2026 Jan 13:gutjnl-2025-337019. doi: 10.1136/gutjnl-2025-337019.
    >> Share


    Hepatology

  12. WANG W, Yin S, Xu Q, Song D, et al
    Biologically interpretable deep learning-derived MRI phenotypes reveal lymph node involvement and neoadjuvant therapy response in intrahepatic cholangiocarcinoma.
    Hepatology. 2026 Jan 12. doi: 10.1097/HEP.0000000000001671.
    >> Share

  13. ZHANG VX, Suoangbaji T, Tsui YM, Sze KM, et al
    Repurposing resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression.
    Hepatology. 2026 Jan 12. doi: 10.1097/HEP.0000000000001675.
    >> Share

  14. ALLAIRE M, Bargellini I
    Hepatocellular carcinoma with macrovascular invasion : Navigating heterogeneous evidence.
    Hepatology. 2026 Jan 14. doi: 10.1097/HEP.0000000000001679.
    >> Share

  15. WANG JJ, Lee YT, Kim AK, Villauneva A, et al
    Clinical utilization of testing for cell-free DNA in hepatocellular cancer.
    Hepatology. 2026 Jan 14. doi: 10.1097/HEP.0000000000001676.
    >> Share

  16. ERICKSON H
    Fueling fibrosis: The PBX1-IL7R axis and its role in hepatic stellate cell activation.
    Hepatology. 2026;83:197-198.
    >> Share

  17. DING W, Wu J, Dou J, Liu F, et al
    Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma.
    Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001678.
    >> Share

  18. YAMAMOTO S, Kodama T, Kuwano A, Maesaka K, et al
    NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
    Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001677.
    >> Share

  19. ALLEN AM, Kim WR, Carrieri P, Canning R, et al
    Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease.
    Hepatology. 2026;83:362-373.
    >> Share

  20. LAI JC, Shui AM, Molinari M, Rahimi R, et al
    The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.
    Hepatology. 2025 Mar 25. doi: 10.1097/HEP.0000000000001320.
    >> Share


    J Gastroenterol Hepatol

  21. KO KA, Sohn W
    Response to the Letter on "Role of ALBI Grade as a Predictive Factor for Long-Term Mortality in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)".
    J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1111/jgh.70246.
    >> Share

  22. INOUE T, Kitano R, Kitada T, Sakamoto K, et al
    Endoscopic Ultrasound-Guided Bilateral Stent-in-Stent Deployment With Hepaticoenterostomy in patients With Malignant Hilar Biliary Obstruction.
    J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1111/jgh.70236.
    >> Share


    J Hepatol

  23. LUUKKONEN PK
    Redox-dependent substrate use in hepatic gluconeogenesis shapes exercise performance.
    J Hepatol. 2026 Jan 13:S0168-8278(25)02726-6. doi: 10.1016/j.jhep.2025.
    >> Share

  24. LUO X, Xiang Z, Yang Z
    Emergency granulopoiesis in decompensated cirrhosis: mechanistic and therapeutic considerations.
    J Hepatol. 2026 Jan 9:S0168-8278(26)00005-X. doi: 10.1016/j.jhep.2025.
    >> Share


    PLoS Med

  25. YANG K, Lee J, Jang JW, Sung PS, et al
    Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study.
    PLoS Med. 2026;23:e1004855.
    >> Share


    Radiology

  26. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    >> Share

  27. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    >> Share

  28. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016